{14 (deutetrabenazine 6 MG Oral Tablet [Austedo]) / 14 (deutetrabenazine 9 MG Oral Tablet [Austedo]) } Pack [Austedo 12 MG Starting Dose Pack]

RxNorm concept 2281115, branded pack (bpck). Prescribable name: Austedo Tardive Dyskinesia 12 MG Starting Dose Pack.

RxCUI: 2281115
Term type: Branded pack (BPCK)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2281115 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

deutetrabenazine 1876905

Other names

Austedo 12 MG Starting Dose Pack

Related concepts

deutetrabenazine 6 MG Oral Tablet [Austedo] (SBD, contains)
deutetrabenazine 9 MG Oral Tablet [Austedo] (SBD, contains)
Pack (DF, has dose form)
{14 (deutetrabenazine 6 MG Oral Tablet) / 14 (deutetrabenazine 9 MG Oral Tablet) } Pack (GPCK, tradename of)

Linked data

NDCs

68546017628

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2281115 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2281115 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2281115. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.